Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-alpha therapy on clinical outcome and histological pattern.
Morosetti
M
M
Chair of Clinical Surgery, University of Rome Tor Vergata, Italy.
Sciarra
G
G
Meloni
C
C
Palmieri
G
G
Palombo
G
G
Taccone Gallucci
M
M
Casciani
C U
CU
D000998:Antiviral Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003449:Cryoglobulinemia / Q000150:complications / Q000473:pathology / Q000628:therapy*; D005260:Female; D015432:Glomerulonephritis, Membranoproliferative / Q000150:complications / Q000473:pathology / Q000628:therapy*; D006526:Hepatitis C / Q000150:complications / Q000473:pathology / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D016896:Treatment Outcome
D000998:Antiviral Agents; D016898:Interferon-alpha